Everest Medicines Announces New Drug Application Acceptance by the Pharmaceutical Administration Bureau of Macao for Nefecon® for the Treatment of Primary IgA Nephropathy ...Middle East

SHANGHAI, Aug. 24, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative medicines and vaccines, announced today that the Pharmaceutical Administration...

Hence then, the article about everest medicines announces new drug application acceptance by the pharmaceutical administration bureau of macao for nefecon for the treatment of primary iga nephropathy was published today ( Friday 25/08/2023 - 03:32 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Everest Medicines Announces New Drug Application Acceptance by the Pharmaceutical Administration Bureau of Macao for Nefecon® for the Treatment of Primary IgA Nephropathy )

Also on site :

• TJ Maxx Is Selling a Lookalike of a Popular Anthropologie Doormat Over 3x the Price
• Joanna Gaines Reveals the Awkward Moment Chip’s Proposal Went Wrong
• Musk mulling mega-mergers – Bloomberg